A high percentage of patients undergoing treatment for cancer achieved a sufficient antibody response to the BNT162b2 messenger RNA COVID-19 vaccine, according to study results published in JAMA Oncology.“Patients and health care providers had been extremely preoccupied wondering if patients with active cancer could develop antibodies [after] COVID-19 vaccination,” Salomon M. Stemmer,
With deep quantum modeling, researchers can go beyond the millions of distinct chemical structures previously accessible to scientists and explore 1060 possible combinations to find…
Websites focused on inhaler technique frequently overlook important preparation steps and device care/maintenance, according to results published in Respiratory Medicine.These findings emphasize the importance of…
Penumbra announced the FDA clearance and launch of its next-generation computer-assisted vacuum thrombectomy system to remove venous thrombus and treat pulmonary emboli.The thrombectomy system (Lightning…
Less than optimal heart health at midlife was associated with a decline in the mental processing speed of Black women, but not white women, researchers…
ATLANTA — Adults genetically predisposed to high stress are more likely to have a heart attack during times of heightened stress, such as a major…
Endoscopic sleeve gastroplasty was more cost-effective and sustained greater weight loss over 5 years compared with semaglutide for patients with class II obesity, according to…
Websites focused on inhaler technique frequently overlook important preparation steps and device care/maintenance, according to results published in Respiratory Medicine.These findings emphasize the importance of…
Implementing the recent stronger standard for fine particulate pollution revealed that 131 million Americans breathe unhealthy, polluted air where they live, according to a press…
Patients in rheumatoid arthritis remission who tapered off conventional synthetic disease-modifying antirheumatic drugs had higher risks for flares, with two methods failing to reach non-inferiority…
Vonoprazan was noninferior to high-dose IV proton pump inhibitor therapy in preventing 30-day rebleeding among patients with high-risk peptic ulcer bleeding who had achieved endoscopic…
